BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8691317)

  • 1. Lung tumours immunoreactive for parathyroid hormone related peptide: analysis of serum calcium levels and tumour type.
    Davidson LA; Black M; Carey FA; Logue F; McNicol AM
    J Pathol; 1996 Apr; 178(4):398-401. PubMed ID: 8691317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone-related protein (PTHrP) gene expression in solid tumours associated with normocalcaemia and hypercalcaemia.
    Dunne FP; Lee S; Ratcliffe WA; Hutchesson AC; Bundred NJ; Heath DA
    J Pathol; 1993 Nov; 171(3):215-21. PubMed ID: 8277370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients.
    Nishigaki Y; Ohsaki Y; Toyoshima E; Kikuchi K
    Clin Cancer Res; 1999 Jun; 5(6):1473-81. PubMed ID: 10389935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of neural-cadherin in pulmonary epithelial tumours.
    Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV
    Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of parathyroid hormone-related peptide in human thyroid tumours.
    Nakashima M; Ohtsuru A; Luo WT; Nakayama T; Enomoto H; Usa T; Kiriyama T; Ito M; Nagataki S; Yamashita S
    J Pathol; 1995 Feb; 175(2):227-36. PubMed ID: 7738719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-specific survival advantage with parathyroid hormone-related protein in non-small cell lung carcinoma patients.
    Hastings RH; Laux AM; Casillas A; Xu R; Lukas Z; Ernstrom K; Deftos LJ
    Clin Cancer Res; 2006 Jan; 12(2):499-506. PubMed ID: 16428492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.
    Deans C; Wigmore S; Paterson-Brown S; Black J; Ross J; Fearon KC
    Cancer; 2005 May; 103(9):1810-8. PubMed ID: 15800880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the receptor for parathyroid hormone-related protein in normal and malignant breast tissue.
    Downey SE; Hoyland J; Freemont AJ; Knox F; Walls J; Bundred NJ
    J Pathol; 1997 Oct; 183(2):212-7. PubMed ID: 9390035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of parathyroid hormone-related peptide (PTHrP) in gastric tumours.
    Alipov GK; Ito M; Nakashima M; Ikeda Y; Nakayama T; Ohtsuru A; Yamashita S; Sekine I
    J Pathol; 1997 Jun; 182(2):174-9. PubMed ID: 9274527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone-related protein varies with sex and androgen status in nonsmall cell lung cancer.
    Montgrain PR; Quintana R; Rascon Y; Burton DW; Deftos LJ; Casillas A; Hastings RH
    Cancer; 2007 Sep; 110(6):1313-20. PubMed ID: 17676588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological implications of parathyroid hormone-related protein in human colorectal tumours.
    Nishihara M; Ito M; Tomioka T; Ohtsuru A; Taguchi T; Kanematsu T
    J Pathol; 1999 Jan; 187(2):217-22. PubMed ID: 10365097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
    Wang DG; Johnston CF; Sloan JM; Buchanan KD
    J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma.
    Takai E; Yano T; Iguchi H; Fukuyama Y; Yokoyama H; Asoh H; Ichinose Y
    Cancer; 1996 Oct; 78(7):1384-7. PubMed ID: 8839542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of the PTHrP gene in squamous carcinomas predicts the occurrence of hypercalcemia in athymic mice.
    Wysolmerski JJ; Vasavada R; Foley J; Weir EC; Burtis WJ; Kukreja SC; Guise TA; Broadus AE; Philbrick WM
    Cancer Res; 1996 Mar; 56(5):1043-9. PubMed ID: 8640759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
    Pelosi G; Pasini F; Olsen Stenholm C; Pastorino U; Maisonneuve P; Sonzogni A; Maffini F; Pruneri G; Fraggetta F; Cavallon A; Roz E; Iannucci A; Bresaola E; Viale G
    J Pathol; 2002 Sep; 198(1):100-9. PubMed ID: 12210069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head and neck squamous cell carcinoma: measurement of plasma parathyroid hormone-related protein and serum and urine calcium concentrations.
    Sellers RS; Schuller DE; Sharma PK; Tannehill-Gregg SH; Capen CC; Rosol TJ
    Otolaryngol Head Neck Surg; 2000 Nov; 123(5):558-62. PubMed ID: 11077340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers.
    Senden NH; Timmer ED; de Bruïne A; Wagenaar SS; Van de Velde HJ; Roebroek AJ; Van de Ven WJ; Broers JL; Ramaekers FC
    J Pathol; 1997 May; 182(1):13-21. PubMed ID: 9227337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular expression of interleukin 2 (IL-2) and its receptor (IL-2R, CD25) in lung tumours.
    Kasprzak A; Olejniczak K; Przybyszewska W; Zabel M
    Folia Morphol (Warsz); 2007 Aug; 66(3):159-66. PubMed ID: 17985312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.